LPS may enhance expression and release of HMGB1 in human nasal epithelial cells in vitro;Espressione e rilascio della proteina HMGB1 da coltura di cellule epiteliali nasali dopo stimolazione con LPS

Acta Otorhinolaryngologica Italica

Volumn 33, Issue 6, 2013, Pages 398-404

  Chen, D ^a   Bellussi, Luisa Maria ^b   Passali, D ^b   Chen, L ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

HMGB1 protein; Human nasal epithelial cells; Lipopolysaccharides; Nasal polyps; Primary cell culture

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE;

BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; METABOLISM; NOSE MUCOSA;

CELLS, CULTURED; EPITHELIAL CELLS; HMGB1 PROTEIN; HUMANS; LIPOPOLYSACCHARIDES; NASAL MUCOSA;

EID: 84892599821     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Van CK, Zhang N, Gevaert P, Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol 2011;128:728-32.
2. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012;50:1-12.
3. Passali D, Berstein JM, Passali FM, et al. Treatment of recurrent chronic hyper-plastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 2003;129:656-9.
4. Rowe-Jones JM, Medcalf M, Durham SR, et al. Functional endoscopic sinus surgery: 5 year follow-up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005;43:2-10.
5. Nassima F, Séverine L, Alexander K. Expression of high mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:917-27.
6. Shim EJ, Chun E, Lee HS, et al. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy 2012;42:958-65.
7. Rowe SM, Jackson PL, Liu G, et al. Potential role of highmobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 2008;178:822-31.
8. Wang H, Bloom O, Zhang M, et al. HMGB-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-51.
9. Li J, Xie H, Wen T, et al. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 2010;37:766-75.
10. Daly KA, Liu S, Agrawal V, et al. Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling. Biomaterials 2012;33:91-101.
11. Liu Y, Wang ZB, Liu Z, et al. The expression of HMGB1 in nasal mucosa of allergic rhinitis patients and its significance. Zhong Hua Mian Yi Xue Za Zhi 2010;26:651-4.
12. Ferhani N, Letuve S, Kozhich A, et al. Expression of highmobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:917-27.
13. Wu CX, Sun H, Liu Q. LPS Induces HMGB1 relocation and release by activating the NF-rB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7. J Surg Res 2012;175:88-100.
14. Passali D, Kern E, Lei Chen R. High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases. Acta Otorhinolaryngol Ital 2012;32:46-7.
15. Bellussi LM, Chen L, Chen D, et al. The role of high mobility group box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngol Ital 2012;32:386-92.
16. Million K, Tournier F, Houcine O, et al. Effects of retinoic acid receptor-selective agonists on human nasal epithelial cell differentiation. Am J Repair Cell Mol Biol 2001;25:744-50.
17. Lai Y, Chen B, Shi J, et al. Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhino-sinusitis. J Allergy Clin Immunol 2011;128:1207-15.
18. Masaki T, Kojima T, Okabayashi T, et al. A nuclear factor-kappaB signaling pathway via protein kinase C delta regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells. Mol Biol Cell 2011;22:2144-56.
19. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:37-42.
20. Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011;128:549-56, e1-12.
21. Thorley AJ, Ford PA, Giembycz MA, et al. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type ii epithelial cells and macrophages. J Immunol 2007;178:463-73.
22. Eisenbarth SC. Dependent T helper cell type responses to inhaled antigen. J Exp Med 2002;12:1645-51.
23. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late ediator of endotoxin lethality in mice. Science 1999;285:248-51.
24. Wang H, Yang H, Czura CJ, et al. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001;164:1768-73.
25. Deriy LV, Beno DW, Uhing MR, et al. Splenectomy ablates endotoxin-induced IFN-eeresponse in rats. Shock 2002;17:312-5.
26. Lauriello M, Micera A, Muzi P, et al. TLR4 and TLR9 expression in different phenotypes of rhinitis. Int J Otolaryngol 2012;2012:925164.
27. Chin-Feng L, Ching-Hwa T, Chiung-Hsiang C, et al. Expression of Toll-like receptors in cultured nasal epithelial cells. Acta Otolaryngol 2007;127:395-402.
28. Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551-60.
29. Gardella S, Andrei C, Ferrera D, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesiclemediated secretory pathway. EMBO Rep 2002;3:995-1001.
30. Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-60.
31. Park JS, Svetkauskaite D, He Q, et al. Involvement of Tolllike receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7.
32. Kokkola R, Andersson A, Mullins G, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005;61:1-9.
33. Curtin JF, Liu N, Candolfi M, et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. Plos Med 2009;6:e10.